X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Sun Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs SUN PHARMA - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. SUN PHARMA WOCKHARDT LTD./
SUN PHARMA
 
P/E (TTM) x 18.3 15.7 116.3% View Chart
P/BV x 1.9 3.7 50.4% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 WOCKHARDT LTD.   SUN PHARMA
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-16
SUN PHARMA
Mar-16
WOCKHARDT LTD./
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs2,0001,201 166.6%   
Low Rs706706 99.9%   
Sales per share (Unadj.) Rs403.7117.5 343.7%  
Earnings per share (Unadj.) Rs29.519.6 150.4%  
Cash flow per share (Unadj.) Rs42.423.8 178.0%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.1 0.0%  
Book value per share (Unadj.) Rs323.4130.5 247.8%  
Shares outstanding (eoy) m110.512,406.60 4.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.48.1 41.3%   
Avg P/E ratio x45.948.7 94.3%  
P/CF ratio (eoy) x31.940.1 79.7%  
Price / Book Value ratio x4.27.3 57.2%  
Dividend payout %05.1 0.0%   
Avg Mkt Cap Rs m149,5092,294,813 6.5%   
No. of employees `0007.414.7 50.0%   
Total wages/salary Rs m9,44347,971 19.7%   
Avg. sales/employee Rs Th6,048.619,169.8 31.6%   
Avg. wages/employee Rs Th1,280.23,253.0 39.4%   
Avg. net profit/employee Rs Th441.53,197.9 13.8%   
INCOME DATA
Net Sales Rs m44,614282,697 15.8%  
Other income Rs m9706,170 15.7%   
Total revenues Rs m45,584288,867 15.8%   
Gross profit Rs m5,03883,239 6.1%  
Depreciation Rs m1,42610,135 14.1%   
Interest Rs m1,0124,769 21.2%   
Profit before tax Rs m3,57074,505 4.8%   
Minority Interest Rs m-65-11,126 0.6%   
Prior Period Items Rs m6-19 -34.2%   
Extraordinary Inc (Exp) Rs m0-6,852 0.0%   
Tax Rs m2559,349 2.7%   
Profit after tax Rs m3,25747,159 6.9%  
Gross profit margin %11.329.4 38.4%  
Effective tax rate %7.112.5 56.9%   
Net profit margin %7.316.7 43.8%  
BALANCE SHEET DATA
Current assets Rs m39,906308,646 12.9%   
Current liabilities Rs m18,423132,477 13.9%   
Net working cap to sales %48.262.3 77.3%  
Current ratio x2.22.3 93.0%  
Inventory Days Days9083 108.7%  
Debtors Days Days9888 111.9%  
Net fixed assets Rs m35,832133,606 26.8%   
Share capital Rs m5532,407 23.0%   
"Free" reserves Rs m30,370266,909 11.4%   
Net worth Rs m35,739314,042 11.4%   
Long term debt Rs m16,54231,167 53.1%   
Total assets Rs m79,522542,196 14.7%  
Interest coverage x4.516.6 27.2%   
Debt to equity ratio x0.50.1 466.4%  
Sales to assets ratio x0.60.5 107.6%   
Return on assets %5.49.6 56.0%  
Return on equity %9.115.0 60.7%  
Return on capital %8.717.8 48.7%  
Exports to sales %11.614.0 82.9%   
Imports to sales %4.53.1 142.0%   
Exports (fob) Rs m5,17739,572 13.1%   
Imports (cif) Rs m1,9908,882 22.4%   
Fx inflow Rs m7,58942,171 18.0%   
Fx outflow Rs m2,87821,583 13.3%   
Net fx Rs m4,71120,588 22.9%   
CASH FLOW
From Operations Rs m71667,694 1.1%  
From Investments Rs m-8,182-44,549 18.4%  
From Financial Activity Rs m2,543-19,243 -13.2%  
Net Cashflow Rs m-4,9233,902 -126.2%  

Share Holding

Indian Promoters % 74.5 63.7 117.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 5.1 44.8%  
FIIs % 7.7 23.0 33.5%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 8.3 185.5%  
Shareholders   67,757 133,026 50.9%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   PIRAMAL ENTERPRISES  NOVARTIS  DR. DATSONS LABS  DR. REDDYS LAB  GSK PHARMA  

Compare WOCKHARDT LTD. With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Lupin up 4%(01:30 pm)

After opening the day flat, share markets in India remained rangebound and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Aug 24, 2017 03:36 PM

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 5-YR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS